Eli Lilly: Retatrutide Justifies Hype With Best Weight Loss Data Yet - I'm Sold (NYSE:LLY)
礼来礼来(US:LLY) Seeking Alpha·2025-12-11 23:57

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?It's hard to imagine how things could have gone any better for the Pharma giant Eli Lilly and Company ( LLY ) over the past five years, but today it seems they have gotten better still, with theEdmund Ingham is a b ...